Related Experiment Video
Updated: Jul 30, 2026
16:24
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Two erbB-4 transcripts are expressed in normal breast and in most breast cancers
Oncogene
|October 21, 1998
Summary
ErbB-4 (epidermal growth factor receptor family member) expression was investigated in human tumors. Researchers identified two ErbB-4 variants, one lacking a PI3K binding site, suggesting diverse signaling roles in cancer.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- ErbB-4 is a member of the epidermal growth factor receptor (EGFR) family.
- ErbB-4, along with erbB-3, functions as a receptor for neuregulins (NRGs) or heregulins (HRGs).
- Limited information exists on ErbB-4 expression in human tumors compared to EGFR and erbB-2.
Purpose of the Study:
- To investigate the expression of ErbB-4 mRNA in human tumor cell lines and breast tissues.
- To identify and characterize different forms of ErbB-4.
- To explore the potential role of ErbB-4 in breast cancer.
Main Methods:
- Reverse Transcription Polymerase Chain Reaction (RT-PCR) was used to detect ErbB-4 mRNA.
- Southern blotting analysis was employed for further characterization.
- Sequencing of PCR products identified different ErbB-4 variants.
Main Results:
- ErbB-4 mRNA was detected in various breast, ovarian, and glioma tumor cell lines.
- Two ErbB-4 variants were identified: a full-length form (CT-a) and a shorter form (CT-b) lacking a phosphatidylinositol 3-kinase (PI3K) binding site.
- Both ErbB-4 variants were present in normal breast tissues, but only one variant was consistently found in breast tumors.
Conclusions:
- The discovery of two ErbB-4 isoforms suggests differential intracellular signaling pathways and a broader range of cellular responses to heregulin.
- Specific tumor cell lines were identified for further ErbB-4 research.
- The role of ErbB-4 in breast cancer requires additional investigation with larger sample sizes.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...